CompaniesDauntless Pharmaceuticals

Dauntless Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

32

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
Today
Hover over trial bars to see details

Recent Trials

NCT03031535Lead Sponsor
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
PHASE1Completed
32 participants
Started: Jan 31, 2017 · Completed: Mar 31, 2017